David Lavenda

Israel Aerospace Industries Ltd. engages in the development, sale, and maintenance of commercial and military aircrafts, missiles, and military electronic products. It operates through the following segments: Aviation, Military Aircraft, Missiles and Space Systems, and Elta Systems Ltd. The Aviation segment engages in the maintenance, renovation, and improvement of aircraft and aircraft engines, and conversion of passenger aircraft into cargo and refueling aircraft, and in the development and manufacture of aviation assemblies for military and commercial aircraft. The Military Aircraft segment engages in the development, manufacture, and sale of unmanned aircraft. The Missiles and Space Systems segment engages in the development, manufacture, and sale of attack and defense missile systems, satellites, and space assemblies. The Elta Systems Ltd segment engages in the military electronics field. The company was founded in 1953 and is headquartered in Lod, Israel.

Shamir Optical Industry Ltd. engages in the development and manufacture of progressive lenses (multifocal lenses), sharp focus contact lenses, and molds. The company It was founded in 1972 and is headquartered in Shamir, Israel.

Cloverleaf Communications, Inc. develops data storage systems and software services. The company was founded by Elic Yavor and Joseph Klein in 2001 and is headquartered in Woodbury, NY.

Catalyst Investments LP (Management) (Catalyst) is a private equity subsidiary of Cukierman & Co. founded in 1999 by Cukierman Edouard and Yair Shamir. The firm is headquartered in Tel Aviv, Israel.

Infra-Com Ltd. develops optical wireless broadband solutions. The firm's products include IrGT801A audio chipset, evaluation boards, and M2C modules. It develops chipsets for optical wireless audio applications. The company was founded in 1998 by Tamir Shaanan & Yaron Ruziak and is headquartered in Netanya, Israel.

Netivei Israel is an Israeli government company that specializes in the engineering and management of large-scale transport infrastructure projects and programs. The private company has adopted a sustainability approach as a core business strategy and have established nine functional divisions, including innovation and strategy, engineering and development, road network maintenance and operations, railway infrastructure, contracting and engagements, ppp, human capital and organization operations, legal advisor, and finance division. Netivei manages 8,500 kilometers of roads, 105 interchanges, 2,200 intersections, and 1,300 bridges and tunnels in Israel.

N.T.A. - Metropolitan Mass Transit System Ltd. engages in the planning and construction of the mass transportation system in Tel Aviv metropolis. The company was founded in 1997 and is headquartered in Holon, Israel.

Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel.

Gvahim NGO is a non-profit organization based in Tel Aviv, Israel that aims to help new olim integrate into the Israeli labor market. The Israeli company offers training programs and professional support to equip olim with the necessary tools and skills to find suitable employment, build successful careers, and develop their professional networks in Israel. The company's team of HR specialists, career consultants, and professional mentors work closely with each oleh to "repackage" their skills and adapt their experience to meet the demands of the Israeli job market. Gvahim offers various services such as Aliyah Prep, Gvahim Tech, Gvahim Career Center, Business English, Vocational Training, and Gvahim Medical Career Kickstart. The non-profit company also provides guidance on common challenges faced by olim such as language barriers, non-relevant experience for the local market, a new interview process, different working culture, lack of network, and changing professional fields.

Lutris Pharma Ltd. is working on the improvement of the anti-cancer therapy effectiveness and the quality of life for patients that are treated with Epidermal Growth Factor Receptor Inhibitors. The company was founded on December 14, 2015 and is headquartered in Tel Aviv, Israel.